The risk of osteopenia in premenopausal women with various sellar tumors

Gynecological Endocrinology

Volumn 28, Issue 12, 2012, Pages 945-948

  Zhao, Yongbo ^a,b   Gan, Xiaoqiang ^a   Luo, Peng ^a   He, Qiang ^a   Guo, Qindong ^a   Zhang, Lei ^a   Zhang, Xiaorui ^b   Zhang, Xiang ^a   Fei, Zhou ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b 323th Hospital of PLA   (China)

Author keywords

Bone mineral density; Craniopharyngioma; Osteopenia; Prolactinoma; Sellar tumors

Indexed keywords

CORTICOTROPIN; FOLLITROPIN; GROWTH HORMONE; LIOTHYRONINE; LUTEINIZING HORMONE; PROLACTIN; THYROTROPIN;

ADENOMA; ADULT; ARTICLE; BONE DENSITY; BONE MASS; CLINICAL EVALUATION; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CRANIOPHARYNGIOMA; DISEASE DURATION; FEMALE; FOLLITROPIN BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HYPOGONADISM; LIOTHYRONINE BLOOD LEVEL; LUMBAR SPINE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENINGIOMA; NONFUNCTIONING ADENOMA; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PATIENT ASSESSMENT; PREMENOPAUSE; PRIORITY JOURNAL; PROLACTINOMA; RISK FACTOR; SELLA TURCICA TUMOR; THYROTROPIN BLOOD LEVEL; TUMOR VOLUME;

ADENOMA; ADOLESCENT; ADULT; BONE DENSITY; BONE DISEASES, METABOLIC; CHINA; CRANIOPHARYNGIOMA; FEMALE; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; HUMANS; HYPOGONADISM; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; OSTEOPOROSIS; PITUITARY NEOPLASMS; PREMENOPAUSE; PROLACTINOMA; RISK FACTORS; SKULL BASE NEOPLASMS; TIME FACTORS; YOUNG ADULT;

EID: 84870047545     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2012.683080     Document Type: Article

References (22)

1. Molitch ME, Russell EJ. Te pituitary "incidentaloma". Ann Intern Med 1990;112:925-931.
2. Saeger W, Lüdecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S. Pathohistological classifcation of pituitary tumors:10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 2007;156:203-216.
3. Glezer A, Paraiba DB, Bronstein MD. Rare sellar lesions. Endocrinol Metab Clin North Am 2008;37:195-211, x.
4. Zadrozna-Sliwka B, Bolanowski M, Kaluzny M, Syrycka J. Bone mineral density and bone turnover in hyperprolactinaemia of various origins. Endokrynol Pol 2007;58:116-122.
5. Tütüncü NB, Erbas T. Factors associated with bone metabolism in acromegalic patients: hypogonadism and female gender. Exp Clin Endocrinol Diabetes 2004;112:328-332.
6. Matsuyama J, Eshima N, Fukunaga T, Hori S, Kobayashi H, Isono M. Various risks of osteoporosis in patients with pituitary adenomas. J Bone Miner Metab 2003;21:91-97.
7. Bolanowski M, Daroszewski J, Medras M, Zadrozna-Sliwka B. Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function. J Bone Miner Metab 2006;24:72-78.
8. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. Te diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-1141.
9. Rothman MS, Wierman ME. Female hypogonadism: evaluation of the hypothalamic-pituitary-ovarian axis. Pituitary 2008;11:163-169.
10. Müller HL, Schneider P, Bueb K, Etavard-Gorris N, Gebhardt U, Kolb R, Sörensen N. Volumetric bone mineral density in patients with childhood craniopharyngioma. Exp Clin Endocrinol Diabetes 2003;111:168-173.
11. Okinaga H, Matsuno A, Okazaki R. High risk of osteopenia and bone derangement in postsurgical patients with craniopharyngiomas, pituitary adenomas and other parasellar lesions. Endocr J 2005;52:751-756.
12. Holmer H, Popovic V, Ekman B, Follin C, Siversson AB, Erfurth EM. Hypothalamic involvement and insufcient sex steroid supplementation are associated with low bone mineral density in women with childhood onset craniopharyngioma. Eur J Endocrinol 2011;165:25-31.
13. Vartej P, Poiana C, Vartej I. Efects of hyperprolactinemia on osteoporotic fracture risk in premenopausal women. Gynecol Endocrinol 2001;15:43-47.
14. Greenspan SL, Neer RM, Ridgway EC, Klibanski A. Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med 1986;104:777-782.
15. Di Somma C, Colao A, Di Sarno A, Klain M, Landi ML, Facciolli G, Pivonello R, et al. Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males. J Clin Endocrinol Metab 1998;83:807-813.
16. Lindsay R. Estrogen defciency. In: Riggs BL, Melton LJ III, editors. Osteoporosis-etiology, diagnosis and management. 2nd edition. USA: Lippincott-Raven; 1995. 137-152.
17. Bolanowski M, Zadrozna-Sliwka B, Jawiarczyk A, Syrycka J. Te infuence of other than prolactin hormones on bone mineral density in women with hyperprolactinaemia of various origins. Gynecol Endocrinol 2010;26:623-627.
18. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM. Reduced bone mineral density in patients with adult onset growth hormone defciency. J Clin Endocrinol Metab 1994;78:669-674.
19. Riggs BL, Randall RV, Wahner H W, Jowsey J, Kelly PJ, Singh M. Te nature of the metabolic bone disorder in acromegaly. J Clin Endocrinol Metab 1972;34:911-918.
20. Kayath MJ, Vieira JG. Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine. Osteoporos Int 1997;7:226-230.
21. Rubin MR, Schussheim DH, Kulak CA, Kurland ES, Rosen CJ, Bilezikian J P, Shane E. Idiopathic osteoporosis in premenopausal women. Osteoporos Int 2005;16:526-533.
22. Hui SL, Perkins AJ, Zhou L, Longcope C, Econs MJ, Peacock M, McClintock C, Johnston CC Jr. Bone loss at the femoral neck in premenopausal white women: efects of weight change and sex-hormone levels. J Clin Endocrinol Metab 2002;87:1539-1543.